As patients with good collateral flow experience more favorable stroke outcomes and metabolic risk factors such as diabetes are associated with poor leptomeningeal collateral status [18], investigating the role of Gal-4 in this respect may be promising. This evidence concerns the gene LGALS4 and diabetes mellitus.